Ligand profile
ZINC100620818
Virtual-screening candidate from ZINC.
Bound to: HT085_RS00085 — triose-phosphate isomerase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100620818- UniProt (similar protein)
Q6GIL6- Tanimoto
- 0.531
- Target protein
- HT085_RS00085
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 197.4
- −1 ≤ LogP ≤ 5 -4.34
- MW ≤ 500 Da 334.2
- LogP ≤ 5 -4.34
- H-bond donors ≤ 5 8
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 197.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=[P@@](O)(OC[C@H](O)CO)O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OO=[P@@](O)(OC[C@H](O)CO)O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
InChI=1S/C9H19O11P/c10-1-3(11)2-19-21(17,18)20-9-7(15)5(13)4(12)6(14)8(9)16/h3-16H,1-2H2,(H,17,18)/t3-,4-,5-,6+,7+,8+,9-/m1/s1InChI=1S/C9H19O11P/c10-1-3(11)2-19-21(17,18)20-9-7(15)5(13)4(12)6(14)8(9)16/h3-16H,1-2H2,(H,17,18)/t3-,4-,5-,6+,7+,8+,9-/m1/s1
BMVUIWJCUQSHLZ-SLDVFWOTSA-NBMVUIWJCUQSHLZ-SLDVFWOTSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- G3P
- Homolog
- Q6GIL6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100620818 →
- ZINC ZINC20 ZINC100620818 →
- UniProt UniProt Q6GIL6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100620818”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00085.
PDB 10
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).